Drug Updates

Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Collaboration

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries to discover therapeutic antibodies against multiple targets provided by Boehringer Ingelheim. “Boehringer Ingelheim believes Twist’s ability to […]